Smoerum, Denmark

Peter Holm Tygesen

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Vaerlose, DK (2015 - 2017)
  • Smoerum, DK (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Holm Tygesen

Introduction

Peter Holm Tygesen is a notable inventor based in Smoerum, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that are resistant to abuse. With a total of 8 patents to his name, Tygesen's work is recognized for its potential impact on pain management and drug safety.

Latest Patents

Among his latest patents, Tygesen has developed pharmaceutical compositions that provide immediate release for oral administration while being resistant to abuse. This innovation addresses a critical need in the pharmaceutical industry, ensuring that medications can be used safely and effectively. Additionally, he has worked on abuse deterrent pharmaceutical compositions that offer controlled release, further enhancing the safety profile of pain treatment options.

Career Highlights

Tygesen's career is marked by his dedication to improving pharmaceutical formulations. His work has not only contributed to the advancement of drug safety but has also positioned him as a key figure in the industry. His innovative approaches have garnered attention and respect from peers and professionals alike.

Collaborations

Throughout his career, Tygesen has collaborated with talented individuals such as Jan Martin Oevergaard and Karsten Lindhardt. These partnerships have fostered a creative environment that has led to groundbreaking advancements in pharmaceutical technology.

Conclusion

Peter Holm Tygesen's contributions to the field of pharmaceuticals exemplify the importance of innovation in drug safety and efficacy. His work continues to influence the industry, paving the way for safer medication options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…